Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia

Blood

Volumn 99, Issue 8, 2002, Pages 2985-2991

  Le Beau, Michelle M ^a,b   Bitts, Sheila ^a,b   Davis, Elizabeth M ^a,b   Kogan, Scott C ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOME 17; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CONTROLLED STUDY; DISEASE ASSOCIATION; FUSION GENE; GENE EXPRESSION; GENE MUTATION; KARYOTYPING; LEUKEMOGENESIS; MOUSE; MURINE LEUKEMIA; NONHUMAN; PARTIAL TRISOMY; PML RARA GENE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; TRANSGENIC MOUSE;

EID: 0037089420     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.8.2985     Document Type: Article

References (35)

1. Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia
2. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia
3. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
4. 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia
5. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus
6. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML
7. Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemia
8. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences
9. A PMLRAR alpha transgene initiates murine acute promyelocytic leukemia
10. Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice
11. BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor α chimeric protein (PMLRARα) to block neutrophilic differentiation and initiate acute leukemia
12. Cytokine stimulation cooperates with PMLRARα to cause leukemia
13. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors
14. Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL6
15. Cytogenetic analysis of hematologic malignant disease
16. Standard karyotype of the mouse, Mus musculus
17. A photographic representation of the variability in the G-banded structures in the mouse karyotype
18. Secondary chromosome aberrations in the acute leukemias
19. Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice
20. Cytogenetics and neoplasia
21. Cytogenetic deletion maps of hematologic neoplasms: Circumstantial evidence for tumor suppressor loci
22. Cytogenetic studies in acute promyelocytic leukemia: A survey of secondary chromosomal abnormalities
23. Incidence and implication of additional chromosome aberrations in acute promyelocytic leukaemia with translocation t(15;17)(q22;q21): A report of 50 patients
24. Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemia
25. Secondary cytogenetic changes in acute promyelocytic leukemia-prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: A Cancer and Leukemia Group B study
26. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial
27. High frequency of trisomy 8 in acute promyelocytic leukemia: A fluorescence in situ hybridization study
28. Chromosome changes (trisomies 15 and 17) associated with tumor progression in leukemias induced by radiation leukemia virus
29. Chromosome changes (trisomy 15) in murine T-cell leukemia induced by 7, 12-dimethylbenz(a)anthracene (DMBA)
30. Chromosome 15 trisomy in spontaneous and carcinogeninduced murine lymphomas of B-cell origin
31. Distinct chromosomal abnormalities in murine leukemia virus-induced T- and B-cell lymphomas
32. An E mu-BCL-2 transgene facilitates leukaemo-genesis by ionizing radiation
33. Further studies on chromosome 15 trisomy in murine T-cell lymphomas: Mapping of the relevant chromosome segment
34. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics
35. Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics